Takeda: FDA Grants Priority Review Of BLA For Dengue Vaccine

TOKYO (dpa-AFX) - Takeda (TAK) said that the U.S. Food and Drug Administration has granted priority review of the Biologics License Application for TAK-003, the company's investigational dengue

Related Keywords

Puerto Rico , American Samoa , Tokyo , Japan , United States , America , , Drug Administration , More Such Health News , Biologics License Application , Latin America , Takeda , Migrants , Priority , Review , Dengue , Vaccine , Candidate ,